Top Markets
#1 Xeffy Xeffy +17.18%
#2 Arrow Arrow +9.95%
#3 ONFA ONFA +6.21%
#4 DODO DODO +4.28%
#5 Tornado Cash Tornado Cash +2.64%
#6 Unicorn Unicorn +2.39%
#7 KAIO KAIO +2.30%
#8 EVAA Protocol EVAA Protocol +1.92%
#9 Hoodrat Hoodrat +1.83%
#10 Fartcoin Fartcoin +1.59%
Coin of the day
Xeffy Xeffy
Settings
Language
ENGLISH
Currency
USD
Theme
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rank in Stocks #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Share Price
$0.78404857
Market Cap
$36.98M
Change (1 day)
-1.49%
Change (1 year)
139.26%
Country
FR
Trade Theraclion SA (ALTHE)

Category

Healthcare
Revenue for Theraclion SA (ALTHE)
Revenue in Dec 2025 TTM: $1.39M
According to Theraclion SA latest financial reports the company's current revenue (TTM) is $1.39M. In 2023 the company made a revenue of $2.01M an increase over the revenue in the year 2022 that was $1.33M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Theraclion SA from 2010 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.39M 61.11%
2024 $863.67K -57.13%
2023 $2.01M 52.00%
2022 $1.33M -21.31%
2021 $1.68M 85.86%
2020 $906.10K -70.99%
2019 $3.12M 40.16%
2018 $2.23M -34.24%
2017 $3.39M 63.08%
2016 $2.08M 19.81%
2015 $1.73M 74.90%
2014 $991.77K 842.78%
2013 $105.20K 2,658,182.40%
2012 $3.96 -100.00%
2011 $1.21M 326.21%
2010 $284.72K 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $45.13B 3,243,459.15%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.27B 1,815,930.93%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 $36.37B 2,613,687.24%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $20.62B 1,481,398.91%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.30B 452,901.62%
US